Pharma BD Deal Intelligence

Boston Scientific Corporation / Vertiflex, Inc.

2019 · Acquisition/Merger · $465M · Complete

Announcement Sentiment

100

Strongly positive

Boston Scientific agreed to acquire Vertiflex for $465M upfront in cash plus contingent payments through 2021 tied to commercial milestones. Adds the Superion Indirect Decompression System for moderate lumbar spinal stenosis to its pain-management portfolio.

Did it work? Outcome assessment

Strategic verdict

Achieved Stated Rationale

Pipeline outcome

Assets Advanced

Assessment window: 5yr post-close.

Key facts

Announced Jan 22, 2019
Closed Jun 11, 2019
Deal value $465M
Deal type Acquisition/Merger
Therapeutic area Lumbar spinal stenosis
Indications Lumbar spinal stenosis
Key assets Superion Indirect Decompression System
Mechanism Minimally invasive interspinous spacer device

See the full interactive analysis, sources & comparables →

← Browse all deals · How we score deals